Clinicopathological features and management of cancers in lynch syndrome

Pathology Research International

Volumn 2012, Issue , 2012, Pages

  Aarnio, Markku ^a  

^a JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866262267     PISSN: None     EISSN: 2042003X     Source Type: Journal    
DOI: 10.1155/2012/350309     Document Type: Review

References (63)

1. Aaltonen L., Johns L., Järvinen H., Mecklin J. P., Houlston R., Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clinical Cancer Research 2007 13 1 356 361 2-s2.0-33846332027 10.1158/1078-0432.CCR-06-1256
2. Lynch H. T., de la Chapelle A., Hereditary colorectal cancer. New England Journal of Medicine 2003 348 10 919 932 2-s2.0-0037422027 10.1056/NEJMra012242
3. Abdel-Rahman W. M., Mecklin J. P., Peltomaki P., The genetics of HNPCC: application to diagnosis and screening. Critical Reviews in Oncology / Hematology 2006 58 3 208 220
4. Lynch H. T., Smyrk T., Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 1996 78 6 1149 1167
5. Aarnio M., Sankila R., Pukkala E., Salovaara R., Aaltonen L. A., De La Chapelle A., Peltomäki P., Mecklin J. P., Järvinen H. J., Cancer risk in mutation carriers of DNA-mismatch-repair genes. International Journal of Cancer 1999 81 2 214 218 2-s2.0-0032941343
6. Watson P., Vasen H. F. A., Mecklin J. P., Bernstein I., Aarnio M., Järvinen H. J., Myrhoj T., Sunde L., Wijnen J. T., Lynch H. T., The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. International Journal of Cancer 2008 123 2 444 449 2-s2.0-44949202465 10.1002/ijc.23508
7. Vasen H. F. A., Mecklin J. P., Meera Khan P., Lynch H. T., The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Diseases of the Colon and Rectum 1991 34 5 424 425 2-s2.0-0025848680
8. Vasen H. F. A., Watson P., Mecklin J. P., Lynch H. T., New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999 116 6 1453 1456 2-s2.0-0033063711 10.1016/S0016-5085(99)70510-X
9. Rodriguez-Bigas M. A., Boland C. R., Hamilton S. R., Henson D. E., Jass J. R., Khan P. M., Lynch H., Perucho M., Smyrk T., Sobin L., Srivastava S., A national cancer institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. Journal of the National Cancer Institute 1997 89 23 1758 1762 2-s2.0-0031551963
10. Umar A., Boland C. R., Terdiman J. P., Syngal S., de la Chapelle A., Rüschoff J., Fishel R., Lindor N. M., Burgart L. J., Hamelin R., Hamilton S. R., Hiatt R. A., Jass J., Lindblom A., Lynch H. T., Peltomaki P., Ramsey S. D., Rodriguez-Bigas M. A., Vasen H. F. A., Hawk E. T., Barrett J. C., Freedman A. N., Srivastava S., Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. Journal of the National Cancer Institute 2004 96 4 261 268 2-s2.0-10744233937
11. Järvinen H. J., Aarnio M., Mustonen H., AktanCollan K., Aaltonen L. A., Peltomäki P., Chapelle A. D. L., Mecklin J., Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000 118 5 829 834 2-s2.0-0034011564
12. Laura R.-S., Butzow R., Leminen A., lehtovirtsa P., Mecklin J. P., Järvinen H. J., Surveillance for endometrial cancer in hereditary nonplyposis colorectal cancer syndrome. International Journal of Cancer 2006 120 4 821 824
13. Peltomäki P., Vasen H., Mutations associated with HNPCC predisposition-update of ICG-HNPCC/INSiGHT mutation database. Disease Markers 2004 20 4-5 269 276 2-s2.0-4544310802
14. Peltomäki P., Role of DNA mismatch repair defects in the pathogenesis of human cancer. Journal of Clinical Oncology 2003 21 6 1174 1179 2-s2.0-0037445248 10.1200/JCO.2003.04.060
15. Aaltonen L. A., Peltomaki P., Leach F. S., Sistonen P., Pylkkanen L., Mecklin J. P., Jarvinen H., Powell S. M., Jen J., Hamilton S. R., Petersen G. M., Kinzler K. W., Vogelstein B., De La Chapelle A., Clues to the pathogenesis of familial colorectal cancer. Science 1993 260 5109 812 816 2-s2.0-0027158031
16. Aaltonen L. A., Peltomaki P., Mecklin J. P., Jarvinen H., Jass J. R., Green J. S., Lynch H. T., Watson P., Tallqvist G., Juhola M., Sistonen P., Hamilton S. R., Kinzler K. W., Vogelstein B., De la Chapelle A., Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Research 1994 54 7 1645 1648 2-s2.0-0028226295
17. van den Bos M., Van Den Hoven M., Jongejan E., Van Der Leij F., Michels M., Schakenraad S., Aben K., Hoogerbrugge N., Ligtenberg M., Van Krieken J. H., More differences between HNPCC-related and sporadic carcinomas from the endometrium as compared to the colon. American Journal of Surgical Pathology 2004 28 6 706 711 2-s2.0-2542465215 10.1097/01.pas.0000126720.49083.11
18. Gylling A., Abdel-Rahman W. M., Juhola M., Nuorva K., Hautala E., Järvinen H. J., Mecklin J. P., Aarnio M., Peltomäki P., Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? a molecular genetic study. Gut 2007 56 7 926 933 2-s2.0-34347209468 10.1136/gut.2006.114876
19. Gylling A. H. S., Nieminen T. T., Abdel-Rahman W. M., Nuorva K., Juhola M., Joensuu E. I., Järvinen H. J., Mecklin J. P., Aarnio M., Peltomäki P. T., Differential cancer predisposition in Lynch syndrome: insights from molecular analysis of brain and urinary tract tumors. Carcinogenesis 2008 29 7 1351 1359 2-s2.0-49349113150 10.1093/carcin/bgn133
20. Vasen H. F. A., Wijnen J. T., Menko F. H., Kleibeuker J. H., Taal B. G., Griffoen G., Nagengast F. M., Meijers-Heijboer E. H., Bertario L., Varesco L., Bisgaard L., Mohr J., Fodde R., Khan P. M., Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996 110 4 1020 1027 2-s2.0-0029806624
21. Mecklin J. P., Jarvinen H. J., Clinical features of colorectal carcinoma in cancer family syndrome. Diseases of the Colon and Rectum 1986 29 3 160 164 2-s2.0-0022648252
22. Vasen H. F. A., Offerhaus G. J. A., Den Hartog Jager F. C. A., Menko F. H., Nagengast F. M., Griffioen G., Van Hogezand R. B., Heintz A. P. M., The tumour spectrum in hereditary non-polyposis colorectal cancer: a study of 24 kindreds in The Netherlands. International Journal of Cancer 1990 46 1 31 34 2-s2.0-0025326851 10.1002/ijc.2910460108
23. Dunlop M. G., Farrington S. M., Carothers A. D., Wyllie A. K., Sharp L., Burn J., Liu B., Kinzler K. W., Vogelstein B., Cancer risk associated with germline DNA mismatch repair gene mutations. Human Molecular Genetics 1997 6 1 105 110 2-s2.0-0031012805 10.1093/hmg/6.1.105
24. Hendriks Y. M. C., Wagner A., Morreau H., Menko F., Stormorken A., Quehenberger F., Sandkuijl L., Moller P., Genuardi M., Van Houwelingen H., Tops C., Van Puijenbroek M., Verkuijlen P., Kenter G., Van Mil A., Meijers-Heijboer H., Tan G. B., Breuning M. H., Fodde R., Wijnen J. T. H., Bröcker-Vriends A. H. J. T., Vasen H., Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 2004 127 1 17 25 2-s2.0-3242670404 10.1053/j.gastro.2004.03.068
25. Mecklin J.-P., Aarnio M., Läärä E., Kairaluoma M. V., Pylvänäinen K., Peltomäki P., Aaltonen L. A., Järvinen H. J., Development of colorectal tumors in colonoscopic surveillance in Lynch Syndrome. Gastroenterology 2007 133 4 1093 1098 2-s2.0-34848873408 10.1053/j.gastro.2007.08.019
26. Mecklin J. P., Sipponen P., Jarvinen H. J., Histopathology of colorectal carcinomas and adenomas in cancer family syndrome. Diseases of the Colon and Rectum 1986 29 12 849 853 2-s2.0-0022978562
27. Lynch H. T., Smyrk T. C., Watson P., Lanspa S. J., Lynch J. F., Lynch P. M., Cavalieri R. J., Boland C. R., Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993 104 5 1535 1549 2-s2.0-0027248156
28. Jass J. R., Colorectal adenomas in surgical specimens from subjects with hereditary non-polyposis colorectal cancer. Histopathology 1995 27 3 263 267 2-s2.0-0029089040
29. Lanspa S. J., Lynch H. T., Smyrk T. C., Strayhorn P., Watson P., Lynch J. F., Jenkins J. X., Appelman H. D., Colorectal adenomas in the Lynch syndromes: results of a colonoscopy screening program. Gastroenterology 1990 98 5 1117 1122 2-s2.0-0025268661
30. Gaglia P., Atkin W. S., Whitelaw S., Talbot I. C., Williams C. B., Northover J. M. A., Hodgson S. V., Variables associated with the risk of colorectal adenomas in asymptomatic patients with a family history of colorectal cancer. Gut 1995 36 3 385 390 2-s2.0-0028967921
31. de Jong A. E., Morreau H., Van Puijenbroek M., Eilers P. H. C., Wijnen J., Nagengast F. M., Griffioen G., Cats A., Menko F. H., Kleibeuker J. H., Vasen H. F. A., The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology 2004 126 1 42 48 2-s2.0-9144237543 10.1053/j.gastro.2003.10.043
32. Vasen H. F. A., Nagengast F. M., Meera Khan P., Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome). The Lancet 1995 345 8958 1183 1184 2-s2.0-0029005780
33. Kouri M., Laasonen A., Mecklin J. P., Jarvinen H., Franssila K., Pyrhonen S., Diploid predominance in hereditary nonpolyposis colorectal carcinoma evaluated by flow cytometry. Cancer 1990 65 8 1825 1829 2-s2.0-0025232703
34. Vasen H. F. A., Möslein G., Alonso A., Bernstein I., Bertario L., Blanco I., Burn J., Capella G., Engel C., Frayling I., Friedl W., Hes F. J., Hodgson S., Mecklin J. P., Moller P., Nagengast F., Parc Y., Renkonen-Sinisalo L., Sampson J. R., Stormorken A., Wijnen J., Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). Journal of Medical Genetics 2007 44 6 353 362 2-s2.0-34250715384 10.1136/jmg.2007.048991
35. Natarajan N., Watson P., Silva-Lopez E., Lynch H. T., Comparison of extended colectomy and limited resection in patients with lynch syndrome. Diseases of the Colon and Rectum 2010 53 1 77 82 2-s2.0-73449139158 10.1007/DCR.0b013e3181c702de
36. Church J. M., Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer. Annals of Medicine 1996 28 6 479 482 2-s2.0-0030451233
37. Järvinen H. J., Aarnio M., Surveillance on mutation carriers of DNA mismatch repair genes. Annales Chirurgiae et Gynaecologiae 2000 89 3 207 210 2-s2.0-0033778107
38. Sankila R., Aaltonen L. A., Jarvinen H. J., Mecklin J. P., Better survival rates in patients with MLH1 -associated hereditary colorectal cancer. Gastroenterology 1996 110 3 682 687 2-s2.0-0030061148 10.1053/gast.1996.v110. pm8608876
39. Watson P., Lin K. M., Rodriquez-Bigas M. A., Smyrk T., Lemon S., Shadhisharan M., Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer 1998 83 2 259 266
40. Kim H., Jen J., Vogelstein B., Hamilton S. R., Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. American Journal of Pathology 1994 145 1 148 156 2-s2.0-0028276666
41. Shibata D., Peinado M. A., Ionov Y., Malkhosyan S., Perucho M., Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nature Genetics 1994 6 3 273 281 2-s2.0-0028362325 10.1038/ng0394-273
42. Flossmann E., Rothwell P. M., Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. The Lancet 2007 369 9573 1603 1613 10.1016/S0140-6736(07)60747-8
43. Cuzick J., Otto F., Baron J. A., Brown P. H., Burn J., Greenwald P., Jankowski J., La Vecchia C., Meyskens F., Senn H. J., Thun M., Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. The Lancet Oncology 2009 10 5 501 507 2-s2.0-65349152488 10.1016/S1470-2045(09)70035-X
44. Burn J., Gerdes A.-M., Macrae F., Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled study. The Lancet 2011 378 9809 2081 2087 10.1016/S0140-6736(11)61049-0
45. Aarnio M., Mecklin J. P., Aaltonen L. A., Nystrom-Lahti M., Jarvinen H. J., Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. International Journal of Cancer 1995 64 6 430 433 2-s2.0-0029585997 10.1002/ijc.2910640613
46. Dunlop M. G., Farrington S. M., Carothers A. D., Wyllie A. K., Sharp L., Burn J., Liu B., Kinzler K. W., Vogelstein B., Cancer risk associated with germline DNA mismatch repair gene mutations. Human Molecular Genetics 1997 6 1 105 110 2-s2.0-0031012805 10.1093/hmg/6.1.105
47. Broaddus R. R., Lynch H. T., Chen L. M., Daniels M. S., Conrad P., Munsell M. F., White K. G., Luthra R., Lu K. H., Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma. Cancer 2006 106 1 87 94 2-s2.0-29744432124 10.1002/cncr.21560
48. Boks D. E. S., Trujillo A. P., Voogd A. C., Morreau H., Kenter G. G., Vasen H. F. A., Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer. International Journal of Cancer 2002 102 2 198 200 2-s2.0-0037058298 10.1002/ijc.10667
49. Dove-Edwin I., Boks D., Goff S., Kenter G. G., Carpenter R., Vasen H. F. A., Thomas H. J. W., The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma. Cancer 2002 94 6 1708 1712 2-s2.0-0037086654 10.1002/cncr.10380
50. Rijcken F. E., Mourits M. J., Kleibeuker J. H., Hollema H., van der Zee A. G., Gynekologic screening in hereditary nonpolyposis colorectal cancer. Gynecologic Oncology 2003 91 1 74 80
51. Nieminen T. T., Gylling A., Abdel-Rahman W. M., Nuorva K., Aarnio M., Renkonen-Sinisalo L., Järvinen H. J., Mecklin J. P., Bützow R., Peltomäki P., Molecular analysis of endometrial tumorigenesis: importance of complex hyperplasia regardless of atypia. Clinical Cancer Research 2009 15 18 5772 5783 2-s2.0-70349439279 10.1158/1078-0432.CCR-09-0506
52. Koornstra J. J., Mourits M. J., Sijmons R. H., Leliveld A. M., Hollema H., Kleibeuker J. H., Management of extracolonic tumours in patients with Lynch syndrome. The Lancet Oncology 2009 10 4 400 408 2-s2.0-63149194159 10.1016/S1470-2045(09)70041-5
53. Vasen H. F. A., Stormorken A., Menko F. H., Nagengast F. M., Kleibeuker J. H., Griffioen G., Taal B. G., Moller P., Wijnen J. T., MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. Journal of Clinical Oncology 2001 19 20 4074 4080 2-s2.0-0035886698
54. Aarnio M., Salovaara R., Aaltonen L. A., Mecklin J. P., Järvinen H. J., Features of gastric cancers in hereditary non-polyposis colorectal cancer syndrome. International Journal of Cancer 1997 74 551 555
55. Lehtola J., Family study of gastric carcinoma: with special reference to histological types. Scandinavian Journal of Gastroenterology 1978 13 supplement 50 1 54
56. Renkonen-Sinisalo L., Sipponen P., Aarnio M., Julkunen R., Aaltonen L. A., Sarna S., Järvinen H. J., Mecklin J. P., No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer. Scandinavian Journal of Gastroenterology 2002 37 5 574 577 2-s2.0-0036000213 10.1080/00365520252903134
57. van der Post R. S., Kiemeney L. A., Ligtenberg M. J. L., Witjes J. A., Hulsbergen-Van De Kaa C. A., Bodmer D., Schaap L., Kets C. M., Van Krieken J. H. J. M., Hoogerbrugge N., Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers. Journal of Medical Genetics 2010 47 7 464 470 2-s2.0-77956105974 10.1136/jmg.2010.076992
58. Myrhoj T., Andersen M. B., Bernstein I., Screening for urinary tract cancer with urine cytology in Lynch syndrome and familial colorectal cancer. Familial Cancer 2008 7 4 303 307 2-s2.0-55949121061 10.1007/s10689-008-9193-9
59. Grindedal E. M., Renkonen-Sinisalo L., Vasen H., Evans G., Sala P., Blanco I., Gronwald J., Apold J., Eccles D. M., Sánchez Á.. A., Sampson J., Järvinen H. J., Bertario L., Crawford G. C., Stormorken A. T., Maehle L., Moller P., Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds. Journal of Medical Genetics 2010 47 2 99 102 2-s2.0-77349086189 10.1136/jmg.2009.068130
60. Mecklin J. P., Jarvinen H. J., Virolainen M., The association between cholangiocarcinoma and hereditary nonpolyposis colorectal carcinoma. Cancer 1992 69 5 1112 1114 2-s2.0-0026547212
61. Schulmann K., Brasch F. E., Kunstmann E., Engel C., Pagenstecher C., Vogelsang H., Krüger S., Vogel T., Knaebel H. P., Rüschoff J., Hahn S. A., Knebel-Doeberitz M. V., Moeslein G., Meltzer S. J., Schackert H. K., Tympner C., Mangold E., Schmiegel W., HNPCC-associated small bowel cancer: clinical and molecular characteristics. Gastroenterology 2005 128 3 590 599 2-s2.0-20244387702 10.1053/j.gastro.2004.12.051
62. Rodriquez-Bigas M. A., Vasen H. F. A., Lynch H. T., Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. Cancer 1998 83 2 240 244
63. Vasen H. F. A., Sanders E. A. C. M., Taal B. G., The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC). International Journal of Cancer 1996 65 4 422 425